Cocrystal Pharma Inc reports results for the quarter ended in March - Earnings Summary

Cocrystal Pharma

15/05/2023 14:31

* Cocrystal Pharma Inc  COCP.OQ  reported a quarterly
adjusted
loss of 64 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 59 cents per share.
    * Reported revenue was zero​; analysts expected $166.67
thousand. 
    * Cocrystal Pharma Inc's reported EPS for the quarter was a
loss
of 64 cents​.
    * The mean earnings estimate of analysts had risen by
about 17.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Cocrystal Pharma Inc shares had risen by 33.2% this
quarter and
gained 35.9% so far this year.
    * The company reported a quarterly loss of $5.19 million.
    * Wall Street's median 12-month price target for Cocrystal
Pharma
Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.59          -0.64          Missed
 Dec. 31 2022      -0.73          -0.55          Beat
 Sep. 30 2022      -0.48          -0.70          Missed
 Jun. 30 2022      -0.52          -3.00          Missed